University of California San Francisco

Give to UCSF
Advanced
739 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Hybrid Cancer Drug Could Be Resistance-Resistant

A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.

Most Asthma Research May Not Apply to African-American Children

Results from the largest single study of the genetic and environmental causes of asthma in African-American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population, raising concerns for clinicians and scientists working to stem the asthma epidemic among African-Americans.

UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy

Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.

Addressing Trauma as a Health Risk

Clinicians at UCSF are taking on trauma as more than just a social issue. They are addressing how it has a staggering impact on a person’s health.

UCSF Research Suggests New Model for Cancer Metastasis

Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer.